Ticker Details
Atyr Pharma, Inc.
IPO Date:	May 12, 2015
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$57.04M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.11 | 4.48%
Avg Daily Range (30 D):	$0.03 | 4.91%
Avg Daily Range (90 D):	$0.04 | 5.73%

Institutional Daily Volume
Avg Daily Volume:	.51M
Avg Daily Volume (30 D):	2.22M
Avg Daily Volume (90 D):	1.97M

Trade Size
Avg Trade Size (Sh.):	280
Avg Trade Size (Sh.) (30 D):	295
Avg Trade Size (Sh.) (90 D):	314

Institutional Trades
Total Institutional Trades:	125
Avg Institutional Trade:	$1.73M
Avg Institutional Trade (30 D):	$4.62M
Avg Institutional Trade (90 D):	$4.62M
Avg Institutional Trade Volume:	.58M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.72M
Avg Closing Trade (30 D):	$4.62M
Avg Closing Trade (90 D):	$4.62M
Avg Closing Volume:	621.9K

News

May 15, 2026 @ 12:00 PM aTyr Pharma Announces First Quarter 2026 Results a... Source: Na

Apr 8, 2026 @ 5:00 PM Interstitial Lung Disease Market to Witness Accele... Source: Delveinsight

Dec 6, 2025 @ 5:58 PM ATYR Lawsuit: Hagens Berman Urges aTyr Pharma Inve... Source: Reed Kathrein

Dec 6, 2025 @ 1:53 PM ATYR CLASS ACTION DEADLINE ALERT: Bragar Eagel & S... Source: Bragar Eagel & Squire, P.C.

Dec 6, 2025 @ 2:38 AM מועד אחרון לת... Source: Rosen Law Firm

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-.73	$-.11	$-.14
Diluted EPS	$-.73	$-.11	$-.14
Revenue	$.19M	$M	$M
Gross Profit
Net Income / Loss	$-70.03M	$-10.79M	$-13.96M
Operating Income / Loss	$-73.29M	$-11.44M	$-14.8M
Cost of Revenue
Net Cash Flow	$-.98M	$-1.17M	$4.12M
PE Ratio